Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods

Indian Journal of Medical Microbiology

Volumn 30, Issue 3, 2012, Pages 264-269

  Ahmad, S ^a   Khan, Z ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

candida DNA; Candida mannan; candidemia; diagnosis; invasive candidiasis; D glucan

Indexed keywords

1,3 BETA DEXTRO GLUCAN; ANTIMANNAN ANTIBODY; FUNGUS ANTIBODY; MANNAN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; BACTERIAL COLONIZATION; BLOOD CULTURE; CANDIDA GLABRATA; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FUNGUS IDENTIFICATION; IMMUNOFLUORESCENCE TEST; INVASIVE CANDIDIASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 84865576986     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.99482     Document Type: Review

References (50)

1. Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL. Potential risk factors for infection with Candida spp. In critically ill patients. Clin Microbiol Infect 2004;10:550-5.
2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
4. Khan ZU, Al-Sweih N, Ahmad S, Khan S, Chandy R, Joseph L, et al. An outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole and fl uconazole. J Clin Microbiol 2007;45:2025-7.
5. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007;20:133-63.
6. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: Data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009;48:1695-703.
7. Chakrabarti A, Chatterjee SS, Rao KL, Zameer MM, Shivaprakash MR, Singhi S, et al. Recent experience with fungaemia: Change in species distribution and azole resistance. Scand J Infect Dis 2009;41:275-84.
8. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fl uconazole use. J Hosp Infect 2002;50:56-65.
9. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
10. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: Comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents 2011;38:65-9.
11. Al-Sweih N, Khan Z, Khan S, Devarajan LV. Neonatal candidaemia in Kuwait: A 12-year study of risk factors, species spectrum and antifungal susceptibility. Mycoses 2009;52:518-23.
12. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: An 8.5-year analysis of susceptibilities of Candida species and other yeast species to fl uconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45:1735-45.
13. Mokaddas EM, Al-Sweih NA, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: A 10-year study. J Med Microbiol 2007;56:255-9.
14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
15. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Simplifi ed sunfl ower (Helianthus annuus) seed agar for differentiation of Candida dubliniensis from Candida albicans. Clin Microbiol Infect 2004;10:590-2.
16. Asadzadeh M, Ahmad S, Al-Sweih N, Khan ZU. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol 2009;58:745-52.
17. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fl uconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006;43:25-31.
18. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, et al. D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205.
19. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: Useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999;37:1510-7.
20. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-®-D-glucan, mannan and anti-mannan antibodies, and Candida species-specifi c snPCR in patients with candidaemia. BMC Infect Dis 2007;7:103.
21. Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005;51:95-101.
22. Mokaddas E, Khan ZU, Ahmad S, Nampoory MR, Burhamah M. Value of (1-3)-®-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia. Clin Microbiol Infect 2011;17:1549-53.
23. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, et al. Multicenter clinical evaluation of the (1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005;41:654-9.
24. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1->3)-®-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009;49:1650-9.
25. Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1->3)-®-D- glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis 2010;10:292-7.
26. Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuétara MS, Ramírez P, et al. Clinical signifi cance of the detection of Candida albicans germ tube-specifi c antibodies in critically ill patients. Clin Microbiol Infect 2009;15:592-5.
27. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Semi-nested PCR for diagnosis of candidemia: Comparison with culture, antigen detection, and biochemical methods for species identifi cation. J Clin Microbiol 2002;40:2483-9.
28. Khlif M, Mary C, Sellami H, Sellami A, Dumon H, Ayadi A, et al. Evaluation of nested and real-time PCR assays in the diagnosis of candidaemia. Clin Microbiol Infect 2009;15:656-61.
29. Ahmad S, Mustafa AS, Khan Z, Al-Rifaiy AI, Khan ZU. PCR-enzyme immunoassay of rDNA in the diagnosis of candidemia and comparison with amplicon detection by agarose gel electrophoresis. Int J Med Microbiol 2004;294:45-51.
30. Wallet F, Nseir S, Baumann L, Herwegh S, Sendid B, Boulo M, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2010;15:774-9.
31. Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identifi cation of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006;44:693-9.
32. Gharizadeh B, Norberg E, Löffl er J, Jalal S, Tollemar J, Einsele H, et al. Identifi cation of medically important fungi by the Pyrosequencing technology. Mycoses 2004;47:29-33.
33. Lehmann LE, Hunfeld KP, Emrich T, Haberhausen G, Wissing H, Hoeft A, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008;197:313-24.
34. Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008;36:1487-92.
35. von Lilienfeld-Toal M, Lehmann LE, Raadts AD, Hahn-Ast C, Orlopp KS, Marklein G, et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009;47:2405-10.
36. Lucignano B, Ranno S, Liesenfeld O, Pizzorno B, Putignani L, Bernaschi P, et al. Multiplex PCR allows rapid and accurate with suspected sepsis. J Clin Microbiol 2011;49:2252-8.
37. Avni T, Leibovivi L, Paul M. PCR diagnosis of invasive candidiasis: Systematic review and meta-analysis. J Clin Microbiol 2011;49:665-70.
38. Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis. J Infect 2008;57:307-16.
39. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar: A new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2004;42:4796-8.
40. Ahmad S, Mokaddas E, Al-Sweih N, Khan ZU. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait. Med Princ Pract 2005;14 Suppl 1:S77-83.
41. Peman J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 2010;535:424-33.
42. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 2005;48:347-51.
43. Carvalho A, Costa-De-Oliveira S, Martins ML, Pina-Vaz C, Rodrigues AG, Ludovico P, et al. Multiplex PCR identifi cation of eight clinically relevant Candida species. Med Mycol 2007;45:619-27.
44. Spiess B, Seifarth W, Hummel M, Frank O, Fabarius A, Zheng C, et al. DNA microarray-based detection and identifi cation of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007;45:3743-53.
45. Ahmad S, Khan Z, Mokaddas E, Khan ZU. Isolation and molecular identifi cation of Candida dubliniensis from non-human immunodefi ciency virus-infected patients in Kuwait. J Med Microbiol 2004;56:633-7.
46. Khan ZU, Ahmad S, Al-Sweih N, Al-Obaid I. Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis. J Chemother 2008;20:488-91.
47. Romeo O, Scordino F, Pernice I, Lo Passo C, Criseo G. A multiplex PCR protocol for rapid identifi cation of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J Microbiol Methods 2009;79:117-20.
48. Chowdhary A, Randhawa HS, Khan ZU, Ahmad S, Juneja S, Sharma B, et al. First isolation in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol 2010;48:416-20.
49. Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J, et al. Real-time identifi cation of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of fl ight mass spectrometry. J Clin Microbiol 2010;48:1542-8.
50. Gu Z, Hall TA, Frinder M, Walsh TJ, Hayden RT. Evaluation of repetitive sequence PCR and PCR-mass spectrometry for the identifi cation of clinically relevant Candida species. Med Mycol 2011;23:259-65.